SERA vs SPG · rev $44.0K vs rev $3.55B
Sera Prognostics Inc (SERA) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Sera Prognostics Inc (SERA) is a medical devices company listed on US.
SPG (SPG) common stock.
Latest reported SERA revenue for 2026-06-30 was $44.0K. Net income was -$17.5M. SERA currently screens at market cap $89.1M.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
SERA currently screens at market cap $89.1M. SPG currently screens at market cap $0.
Not investment advice. Open the SERA and SPG stock pages for the full models.
Not investment advice.